We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

111 hedge funds and large institutions have $158M invested in VanEck Biotech ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

463% more call options, than puts

Call options by funds: $2.72M | Put options by funds: $484K

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

16% more capital invested

Capital invested by funds: $136M → $158M (+$21.7M)

6% more funds holding

Funds holding: 105 → 111 (+6)

0.59% less ownership

Funds ownership: 28.06% → 27.47% (-0.59%)

4% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 27

Holders
111
Holders Change
+6
Holders Change %
+5.71%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
26
Reduced
27
Closed
7
Calls
$2.72M
Puts
$484K
Net Calls
+$2.24M
Net Calls Change
+$1.23M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.79M
2
FTUS
Flow Traders U.S.
New York
+$1.54M
3
WANY
Wealthspire Advisors (New York)
New York
+$1.37M
4
PP
Prudential plc
United Kingdom
+$931K
5
Millennium Management
Millennium Management
New York
+$589K

Top Sellers

Rank Fund Capital Flow
1
FP
Financial Perspectives
Minnesota
-$2.86M
2
KAS
Kestra Advisory Services
Texas
-$2.1M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.05M
4
BRC
BHF RG Capital
Arizona
-$1.96M
5
Goldman Sachs
Goldman Sachs
New York
-$527K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
101
Fidelity Investments
Massachusetts
$13K +$2.42K +13 +25%
ADL
102
Asset Dedication LLC
California
$12K – – –
AA
103
Ancora Advisors
Ohio
$10K – – –
SWM
104
Spire Wealth Management
Virginia
$10K – – –
SIM
105
Sonora Investment Management
Arizona
$10K +$8.94K +48 New
GFPC
106
Global Financial Private Client
Florida
$8.92K – – –
CYG
107
Clean Yield Group
Vermont
$7K +$6.52K +35 New
MA
108
MUFG Americas
New York
$6K – – –
PP
109
Pacifica Partners
Canada
$5K +$4.65K +25 New
AIP
110
Ameritas Investment Partners
Nebraska
$4K – – –
JP Morgan Chase
111
JP Morgan Chase
New York
$3K – – –
TCM
112
Tufton Capital Management
Maryland
– -$219K -1,250 Closed
SPIA
113
Steward Partners Investment Advisory
New York
– -$79.7K -454 Closed
AIC
114
Ameritas Investment Company
Nebraska
– -$65.1K -371 Closed
Simplex Trading
115
Simplex Trading
Illinois
– -$21K -124 Closed
APWM
116
Atlas Private Wealth Management
New York
– -$18K -100 Closed
FP
117
Fiduciary Planning
Florida
– -$9K -50 Closed
SFS
118
Sowell Financial Services
Arkansas
– -$4K -21 Closed
1 2 3 4
5

BBH Hedge Fund Activity: Q2 2021 in Review

111 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2021, worth a combined $158M — up 16% from $136M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BBH positions and 7 closed out — a net gain of 6 holders — while 26 added to existing stakes and 27 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $1.79M. The largest seller was Financial Perspectives, cutting an estimated $2.86M.

  • 111 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2021, up from 105 in Q1 2021.
  • Funds reported $158M of VanEck Biotech ETF stock for Q2 2021, up 16% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q2 2021 and 7 closed out, a net change of +6 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2021 was Susquehanna International Group, an estimated $1.79M added.
  • The largest VanEck Biotech ETF seller in Q2 2021 was Financial Perspectives, an estimated $2.86M sold.

Based on aggregated 13F filings for Q2 2021.